Recruiting Clinical Trials

Displaying 51 - 60 of 227 result(s)
Study Title Condition Phase Location
A Randomized, Multicenter, Open-label Trial Comparing the Effectiveness of an "Inclisiran First" Implementation Strategy to Usual Care on LDL Cholesterol (LDL-C) in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C (≥70 mg/dL) D ... Atherosclerotic Cardiovascular Disease Phase 3
  • Country: 
    United States
A Phase II, Open-label, Single Arm Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Twice Daily Midostaurin (PKC412) Combined With Standard Chemotherapy and as a Single Agent Post-consolidation Therapy in Children With Untreated FLT3-m ... FLT3-mutated Acute Myeloid Leukemia Phase 2
  • Country: 
    United States
  • Country: 
    Austria
  • Country: 
    Czech Republic
  • Country: 
A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive ... Sickle Cell Disease (SCD) Phase 2
  • Country: 
    United States
  • Country: 
    Belgium
  • Country: 
    Brazil
  • Country: 
A 52-week, Two Arm, Randomized, Open-label, Multicenter Study Assessing the Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens for Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration Age-related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration, Retinal Degeneration, Retinal Diseases, Eye Diseases Phase 4
  • Country: 
    Germany
  • Country: 
    Switzerland
A Non-interventional Study Evaluating Injectable Treatments (Ofatumumab, Glatiramer Acetate and Interferon β1) in Patients With Relapsing Multiple Sclerosis [AIOLOS] Relapsing Multiple Sclerosis Not Given
  • Country: 
    Germany
A Twelve-Month, Randomized, Double-Masked, Multicenter, Phase III, Two-Arm Study Comparing the Efficacy and Safety of Brolucizumab 6 mg Versus Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration Neovascular Age-Related Macular Degeneration Phase 3
  • Country: 
    China
A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China Psoriasis Not Given
  • Country: 
    China
A Phase I/Ib, Open-label, Multi-center, Study of DKY709 as a Single Agent and in Combination With PDR001 in Patients With Advanced Solid Tumors Carcinoma, Non-Small-Cell Lung, Melanoma, Nasopharyngeal Carcinoma, Microsatellite Stable Colorectal Cancer, Triple Negative Breast Cancer Phase 1
  • Country: 
    United States
  • Country: 
    Germany
  • Country: 
    Hong Kong
  • Country: 
Regulatory Post-Marketing Surveillance (rPMS) of Xolair® (Xolair® 150mg Powder for Solution for Injection, Xolair® 150mg/1ml Liquid in Pre-filled Syringe, Xolair® 75mg/0.5ml Liquid in Pre-filled Syringe) for Chronic Rhinosinusitis With Nasal Polyps ( ... Chronic Rhinosinusitis With Nasal Polyps Not Given
  • Country: 
    Korea, Republic of
A Phase I, Open-label, Multicenter, Study of WVT078 in Subjects With Relapsed and/or Refractory Multiple Myeloma Multiple Myeloma (MM) Phase 1
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Germany
  • Country: